Lourdes S. Maia
Fiocruz, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 19, 2026
A cohort study of the duration of immunity to yellow fever after 4 years of primary vaccination in children and adults.
Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene
Published: November 27, 2025
Risk factors for post-COVID-19 condition: A case-control study in municipalities of Paraíba and Rio de Janeiro, Brazil.
Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
Published: October 06, 2025
Challenges in developing new tuberculosis vaccines.
Journal: Memorias do Instituto Oswaldo Cruz
Published: October 18, 2024
Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity.
Journal: PLoS neglected tropical diseases
Published: May 17, 2024
Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses.
Journal: Memorias do Instituto Oswaldo Cruz
Published: April 25, 2024
A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis.
Journal: Frontiers in cardiovascular medicine
Published: March 18, 2023
For the return of high vaccination coverage
Journal: Cadernos de saude publica
Published: December 19, 2022
Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response.
Journal: Frontiers in public health
Published: August 11, 2022
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Journal: Vaccine
Published: September 16, 2021
Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.
Journal: Frontiers in cellular and infection microbiology
Published: January 20, 2021
Last Updated: 09/26/2026